These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38640639)

  • 21. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
    Liu X; Liu Y; Zhang Y; Zhang F; Du E
    BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
    Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
    Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of the Immunogenicity of Porcine Circovirus Type 2 DNA Vaccine by Recombinant ORF2 Gene and CpG Motifs.
    Li J; Shi JL; Wu XY; Fu F; Yu J; Yuan XY; Peng Z; Cong XY; Xu SJ; Sun WB; Cheng KH; Du YJ; Wu JQ; Wang JB; Huang BH
    Viral Immunol; 2015 Jun; 28(5):290-6. PubMed ID: 26046831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
    Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
    Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
    Jung BK; Kim HR; Lee YH; Jang H; Chang KS
    J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice.
    Liu X; Ouyang T; Ma T; Ouyang H; Pang D; Ren L
    BMC Vet Res; 2018 Apr; 14(1):137. PubMed ID: 29685143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of single dose of an inactivated porcine circovirus type 2 (PCV2) whole-virus vaccine with oil adjuvant in piglets.
    Yang K; Li W; Niu H; Yan W; Liu X; Wang Y; Cheng S; Ku X; He Q
    Acta Vet Scand; 2012 Nov; 54(1):67. PubMed ID: 23171757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of a Rep' protein antibody detection method to distinguish natural infection with PCV2 from subunit vaccine immunization.
    Chen Q; Rong J; Li G; Xu B; Wang X; Hu J; Rong M; Li H
    J Med Microbiol; 2020 Sep; 69(9):1183-1196. PubMed ID: 32812860
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
    Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
    PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative immunogenic and immunoprotective activities of PCV2d Cap and Rep antigens delivered by an efficient eukaryotic expression system engineered into a Salmonella vaccine vector.
    Lloren KKS; Sivasankar C; Lee JH
    Vet Microbiol; 2024 Aug; 295():110151. PubMed ID: 38870752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cytokine profiles in peripheral blood mononuclear cells between piglets born from Porcine circovirus 2 vaccinated and non-vaccinated sows.
    Oliver-Ferrando S; Segalés J; Sibila M; Díaz I
    Vet Microbiol; 2018 Feb; 214():148-153. PubMed ID: 29408027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immune efficacy in mice by recombinant pseudorabies virus PGO expressing ORF2 gene of porcine circovirus type 2].
    Chao A; Fu P; Guo X; Gao X; Cui B; Chen H
    Wei Sheng Wu Xue Bao; 2014 Feb; 54(2):211-7. PubMed ID: 24818470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A live-attenuated and an inactivated chimeric porcine circovirus (PCV)1-2 vaccine are both effective at inducing a humoral immune response and reducing PCV2 viremia and intrauterine infection in female swine of breeding age.
    Hemann M; Beach NM; Meng XJ; Wang C; Halbur PG; Opriessnig T
    Can J Vet Res; 2014 Jan; 78(1):8-16. PubMed ID: 24396175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses of mice immunized by DNA plasmids encoding PCV2 ORF 2 gene, porcine IL-15 or the both.
    Dong B; Feng J; Lin H; Li L; Su D; Tu D; Zhu W; Yang Q; Ren X
    Vaccine; 2013 Nov; 31(48):5736-44. PubMed ID: 24091312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice.
    Shen HG; Zhou JY; Huang ZY; Guo JQ; Xing G; He JL; Yan Y; Gong LY
    J Gen Virol; 2008 Aug; 89(Pt 8):1857-1865. PubMed ID: 18632956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.